Epithelioid cell type, monosomy 3 and 6p gain, and deletion of the BAP-1 gene are among the histopathologic and tumor-specific genetic abnormalities that are most important for melanoma-specific mortality prediction (3). This evidence concerns the gene BAP1 and melanoma.